Zenas BioPharma, Inc. Common Stock (ZBIO)
Zenas BioPharma, Inc. (ZBIO) is a biopharmaceutical company focused on developing innovative therapies for cancer and immune-related diseases. The company aims to advance novel treatments by leveraging cutting-edge science and targeted approaches to address unmet medical needs in oncology and immunology.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 2, 2020 | $0.00 | 2019-12-24 | 2019-12-26 |
| October 2, 2019 | $0.02 | 2019-09-25 | 2019-09-26 |
| July 2, 2019 | $0.02 | 2019-06-25 | 2019-06-26 |
| March 27, 2019 | $0.01 | 2019-03-20 | 2019-03-21 |
| January 3, 2019 | $0.01 | 2018-12-26 | 2018-12-27 |
Dividends Summary
- Zenas BioPharma, Inc. Common Stock has issued 5 dividend payments over the past 1 years
- The most recent dividend was paid 2105 days ago, on January 2, 2020
- The highest dividend payed out to investors during this period was $0.02 per share
- The average dividend paid during this period was $0.01 per share.
Company News
Pomerantz LLP has filed a class action lawsuit against Zenas BioPharma, Inc. (ZBIO) due to potential securities fraud or unlawful business practices. The lawsuit is related to Zenas's initial public offering in September 2024, where the company allegedly misrepresented its ability to fund operations.
Zenas BioPharma, Inc. (ZBIO) is facing a securities fraud lawsuit alleging the company made false and misleading statements about its financial runway during its IPO.